PERSPECTA

News from every angle

← Back to headlines

Moderna Stock Rallies on Cancer Therapy Trial Win and Upgrade

Moderna's stock is rallying after Wolfe upgraded the company following a successful trial win for its cancer therapy. This positive news has extended the company's gains in the market.

25 Aug, 14:18 — 25 Aug, 14:18
PostShare

Sources

Showing 1 of 2 sources
seeking-alphaMixed8h ago

Moderna extends gains as Wolfe upgrades on trial win for cancer therapy

Read full article →

Coverage Timeline

First report: investing-com · 25 Aug, 09:52Full coverage: 2 · 4hWindow: 4h
Left-leaningCenterRight-leaning
investing-com25 Aug, 09:52First to report

Why is Moderna stock rallying today?

4h later
seeking-alpha25 Aug, 14:18Latest update

Moderna extends gains as Wolfe upgrades on trial win for cancer therapy

Related Stories

Par Pacific to Sell Laramie Energy Assets for $485 Million

25m ago

Executives at Precigen and RingCentral Sell Company Shares

25m ago

Box Reports Strong Q2 2026 Revenue, Lifts Full-Year Outlook

30m ago

ECB and BOJ Expected to Raise Interest Rates in September

38m ago